TMDX Live signals | Maximize Profits with Getagraph.com

SELL 4593 min ago

@ $150.72

Issued: 28 Jun 2024 @ 15:54

Return: -0.35%

Previous signal: Jun 28 - 13:44

Previous signal: Buy

Return: 0.94 %

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.20% compare to its pairs and should correct upwards.

Stats
Today's Volume	603 629
Average Volume	899 767
Market Cap	4.95B
EPS	$0.370 ( Q1 \| 2024-05-02 )
Next earnings date	( $0.210 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-429.11 (Sector) 42.63 (Industry) 0
ATR14	$5.26 (3.51%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-14	Hassanein Waleed H	Sell	8 625	Stock Option (Right to Buy)
2024-06-14	Hassanein Waleed H	Buy	8 625	Common Stock
2024-06-14	Hassanein Waleed H	Sell	1 614	Common Stock
2024-06-14	Hassanein Waleed H	Sell	3 836	Common Stock
2024-06-14	Hassanein Waleed H	Sell	2 675	Common Stock

INSIDER POWER
-36.93
Last 99 transactions
Buy: 160 311 \| Sell: 349 008

Correlation (AI algo v.1.1b): Undervalued: 0.20% $150.36 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.85 (strong negative)

Short: -0.67 (moderate negative)

Signal:(37) Neutral

Transmedics Group Inc Correlation

10 Most Positive Correlations
AGBA	0.901
THCP	0.891
IZEA	0.874
RILY	0.862
NISN	0.845
CHCI	0.844
STCN	0.842
ELYM	0.841
VTSI	0.837
CADL	0.836

10 Most Negative Correlations
ICLK	-0.927
VAXX	-0.892
SECO	-0.859
AGMH	-0.849
CETX	-0.849
LINK	-0.841
HOLI	-0.834
HYPR	-0.821
WVVI	-0.818
TFFP	-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Transmedics Group Inc Correlation - Currency/Commodity

0.53
( weak )

0.43
( neutral )

0.72
( moderate )

-0.09
( neutral )

-0.82
( strong negative )

-0.28
( neutral )

Transmedics Group Inc Financials

Annual	2023
Revenue:	$241.62M
Gross Profit:	$153.99M (63.73 %)
EPS:	$-0.770

FY	2023
Revenue:	$241.62M
Gross Profit:	$153.99M (63.73 %)
EPS:	$-0.770

FY	2022
Revenue:	$93.46M
Gross Profit:	$65.27M (69.84 %)
EPS:	$-1.230

FY	2021
Revenue:	$30.26M
Gross Profit:	$21.16M (69.92 %)
EPS:	$-1.790

Financial Reports:

No articles found.

Transmedics Group Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Transmedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.